Inactive Instrument

Other languages Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

Other languages

Unlock all the news: Be the first to know and act before the market!

Sawai Group Plans 33 Billion Yen Share Buyback; Shares Up 8%	Jun. 25
Sawai Group Holdings Co., Ltd. announces an Equity Buyback for 6,900,000 shares, representing 15.75% for ¥33,000 million.	Jun. 25
Sawai Group Holdings Co., Ltd. authorizes a Buyback Plan.	Jun. 24
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2024 and Fiscal Year Ending March 2025	May. 13
Sawai Group Holdings Co., Ltd. Announces Dividend Guidance for the Second Quarter and Fiscal Year Ending March 31, 2025	May. 13
Sawai Group Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 26, 2024	May. 13
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..	Mar. 31
Sawai Group Holdings Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2024	Feb. 13
Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 13
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Nov. 10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024	23-08-09
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for Period Ending September 2023 and Year Ending March 2024	23-08-09
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half Year Ending September 2023 and Fiscal Year Ending March 31, 2024	23-05-11
Sawai Group Holdings Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 28, 2023; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024	23-05-11
Sawai Group Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-10
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023	23-02-12
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	23-02-12
Sawai Group Holdings Co., Ltd. Announces Dividend for the Second Quarter Ending September 30, 2022, Payable on December 2, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023	22-11-08
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-11-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sawai Pharmaceutical Co., Ltd. Japan Exchange

Equities

4555

JP3323050009

Other languages

Filters